The next step is human clinical trials
The promising results mean there is a lot of work to be done. There is hope on the horizon for progressive multiple sclerosis patients! The plan is to use the drug in clinical studies to see if it helps human patients suffering from multiple sclerosis. On top of that, Dr. Faissner and his team are hoping to improve their understanding the mechanisms underlying this particular disease. They are always looking to find new drugs that can help protect patients with multiple sclerosis.